Europe Vagus Nerve Stimulation Market - Industry Trends and Forecast to 2029
- Published Date: 2022-12-22
- Report ID: 143051
- Pages: 225
-
Format:
Short Description
Europe Vagus Nerve Stimulation Market, By Product Type (Implantable VNS Devices and External VNS Devices), Biomaterial (Ceramics, Metallic, and Polymerics), Application (Pain Management, Epileptic Seizures, Obesity Management, Depression and Anxiety, and Others), Patient Type (Adults, Pediatric, and Geriatric), End User (Hospitals, Ambulatory Surgical Centers, Specialty Centers, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Countriy (Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe) Industry Trends and Forecast to 2029
Market Definition
The vagus nerve is a long cranial nerve that runs from a persons brain stem into the neck, chest, and abdomen. It is a part of the parasympathetic nervous system, which is commonly referred to as the rest-and-digest system because it regulates bodily functions while a person is at rest. It delivers messages to a persons brain from their digestive system and organs such as their lungs, heart, and liver. It controls several organ functions, including digestion, heart rate, and respiratory rate. It is responsible for vasomotor activity and reflexes. It also regulates vocalization, mood, and immunity. It influences sensory functions in a persons ears, sinuses, and esophagus as well.
VNS involves a pulse generator inserted under a persons skin on their chest. The implantable device, which is similar to a pacemaker, delivers regular electrical pulses to the brain via the vagus nerve. It is possible to provide additional stimulation by placing the provided magnet over the pulse generator. Relaxation techniques such as breathing exercises, yoga, and medication can influence vagus nerve activity, increasing its ability to relieve anxiety and mood-related symptoms. VNS can improve an individuals physical health and can offer benefits for several conditions such as epilepsy and depression. The treatment has a healing effect on a persons body due to its ability to promote relaxation and reduce inflammation.
Market Segmentation
Europe vagus nerve stimulation market is categorized into six notable segments based on product type, biomaterial, application, patient type, end user, and distribution channel.
Based on product type, the market is segmented into implantable VNS devices and external VNS devices
Based on biomaterial, the market is segmented into ceramics, metallic, and polymerics
Based on application, the market is segmented into pain management, epileptic seizures, obesity management, depression and anxiety, and others
Based on patient type, the market is segmented into adults, pediatrics, and geriatrics
Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others
Based on distribution channel, the market is segmented into direct tender, retail sales, and others
Market Players
Some of the key market players in the Europe vagus nerve stimulation market are listed below:
electroCore, Inc.
LivaNova PLC
Medtronic
SetPoint Medical
tVNS Technologies GmbH
MicroTransponder Inc.
Others
TABLE OF CONTENTS
1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 OVERVIEW OF EUROPE VAGUS NERVE STIMULATION MARKET 40
1.4 LIMITATIONS 42
1.5 MARKETS COVERED 42
2 MARKET SEGMENTATION 44
2.1 MARKETS COVERED 44
2.2 GEOGRAPHICAL SCOPE 45
2.3 YEARS CONSIDERED FOR THE STUDY 46
2.4 CURRENCY AND PRICING 46
2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
2.6 MULTIVARIATE MODELLING 50
2.7 LIFELINE CURVE , BY PRODUCT TYPE 50
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
2.9 DBMR MARKET POSITION GRID 52
2.10 MARKET APPLICATION COVERAGE GRID 53
2.11 VENDOR SHARE ANALYSIS 54
2.12 SECONDARY SOURCES 55
2.13 ASSUMPTIONS 55
3 EXECUTIVE SUMMARY 56
4 PREMIUM INSIGHTS 59
4.1 PORTERS FIVE FORCES 60
4.2 PESTEL ANALYSIS 61
4.3 KEY STRATEGIC INITIATIVES 62
5 REGULATIONS OF EUROPE VAGUS NERVE STIMULATION MARKET 63
6 MARKET OVERVIEW 67
6.1 DRIVERS 69
6.1.1 INCREASING PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS 69
6.1.2 INNOVATIVE NON-INVASIVE VAGUS NERVE STIMULATION DEVICES INTRODUCED TO MEET DEMAND 70
6.1.3 RISE IN PRODUCT APPROVALS 70
6.1.4 PRODUCT DEVELOPMENT IN RECENT YEARS 71
6.2 RESTRAINTS 71
6.2.1 HIGH MAINTENANCE AND DEVICE COSTS TO RESTRAIN ADOPTION OF VAGUS NERVE STIMULATORS 71
6.2.2 RISE IN PRODUCT RECALL 72
6.2.3 UNFAVORABLE REIMBURSEMENT POLICIES 72
6.3 OPPORTUNITIES 73
6.3.1 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 73
6.3.2 RISING GOVERNMENT INITIATIVES FOR NEUROLOGICAL DISEASE 73
6.4 CHALLENGES 74
6.4.1 RISKS ASSOCIATED WITH THE IMPLANTATION OF THESE DEVICES 74
6.4.2 LACK OF SKILLED HEALTHCARE PROFESSIONALS 74
6.4.3 STRINGENT REGULATIONS FOR APPROVAL OF MEDICAL DEVICES 75
7 EUROPE VAGUS NERVE STIMULATION MARKET, BY PRODUCT TYPE 76
7.1 OVERVIEW 77
7.2 IMPLANTABLE VNS DEVICE 80
7.3 EXTERNAL VNS DEVICE 80
8 EUROPE VAGUS NERVE STIMULATION MARKET, BY BIOMATERIAL 81
8.1 OVERVIEW 82
8.2 METALLIC 85
8.3 POLYMERIC 85
8.4 CERAMICS 86
9 EUROPE VAGUS NERVE STIMULATION MARKET, BY APPLICATION 87
9.1 OVERVIEW 88
9.2 EPILEPTIC SEIZURES 91
9.2.1 IMPLANTABLE VNS DEVICE 91
9.2.2 EXTERNAL VNS DEVICE 91
9.3 DEPRESSION AND ANXIETY 91
9.3.1 IMPLANTABLE VNS DEVICE 92
9.3.2 EXTERNAL VNS DEVICE 92
9.4 PAIN MANAGEMENT 93
9.4.1 IMPLANTABLE VNS DEVICE 93
9.4.2 EXTERNAL VNS DEVICE 93
9.5 OBESITY MANAGEMENT 94
9.5.1 IMPLANTABLE VNS DEVICE 94
9.5.2 EXTERNAL VNS DEVICE 94
9.6 OTHERS 95
10 EUROPE VAGUS NERVE STIMULATION MARKET, BY PATIENT TYPE 96
10.1 OVERVIEW 97
10.2 ADULTS 100
10.2.1 IMPLANTABLE VNS DEVICES 100
10.2.2 EXTERNAL VNS DEVICES 100
10.3 GERIATRIC 101
10.3.1 IMPLANTABLE VNS DEVICES 101
10.3.2 EXTERNAL VNS DEVICES 101
10.4 PEDIATRIC 102
10.4.1 IMPLANTABLE VNS DEVICES 102
10.4.2 EXTERNAL VNS DEVICES 102
11 EUROPE VAGUS NERVE STIMULATION MARKET, BY END USER 103
11.1 OVERVIEW 104
11.2 SPECIALTY CENTERS 107
11.3 HOSPITALS 107
11.4 AMBULATORY SURGICAL CENTERS (ASCS) 108
11.5 OTHERS 108
12 EUROPE VAGUS NERVE STIMULATION MARKET, BY DISTRIBUTION CHANNEL 109
12.1 OVERVIEW 110
12.2 DIRECT TENDER 113
12.3 RETAIL SALES 113
12.4 OTHERS 114
13 EUROPE VAGUS NERVE STIMULATION MARKET, BY REGION 115
13.1 EUROPE 116
13.1.1 GERMANY 124
13.1.2 U.K. 128
13.1.3 ITALY 132
13.1.4 SPAIN 136
13.1.5 FRANCE 140
13.1.6 SWITZERLAND 144
13.1.7 BELGIUM 148
13.1.8 NETHERLANDS 152
13.1.9 RUSSIA 156
13.1.10 TURKEY 160
13.1.11 REST OF EUROPE 164
14 EUROPE VAGUS NERVE STIMULATION MARKET: COMPANY LANDSCAPE 165
14.1 COMPANY SHARE ANALYSIS: EUROPE 165
15 SWOT ANALYSIS 166
16 COMPANY PROFILE 167
16.1 ELECTROCORE, INC. 167
16.1.1 COMPANY SNAPSHOT 167
16.1.2 REVENUE ANALYSIS 167
16.1.3 COMPANY SHARE ANALYSIS 168
16.1.4 PRODUCT PORTFOLIO 168
16.1.5 RECENT DEVELOPMENTS 168
16.2 LIVANOVA PLC 170
16.2.1 COMPANY SNAPSHOT 170
16.2.2 REVENUE ANALYSIS 170
16.2.3 COMPANY SHARE ANALYSIS 171
16.2.4 PRODUCT PORTFOLIO 171
16.2.5 RECENT DEVELOPMENTS 171
16.3 MEDTRONIC 173
16.3.1 COMPANY SNAPSHOT 173
16.3.2 REVENUE ANALYSIS 173
16.3.3 COMPANY SHARE ANALYSIS 174
16.3.4 PRODUCT PORTFOLIO 174
16.3.5 RECENT DEVELOPMENTS 174
16.4 SETPOINT MEDICAL 175
16.4.1 COMPANY SNAPSHOT 175
16.4.2 COMPANY SHARE ANALYSIS 175
16.4.3 PRODUCT PORTFOLIO 176
16.4.4 RECENT DEVELOPMENTS 176
16.5 TVNS TECHNOLOGIES GMBH 177
16.5.1 COMPANY SNAPSHOT 177
16.5.2 COMPANY SHARE ANALYSIS 177
16.5.3 PRODUCT PORTFOLIO 178
16.5.4 RECENT DEVELOPMENT 178
16.6 NEUROPIX COMPANY LTD. 179
16.6.1 COMPANY SNAPSHOT 179
16.6.2 PRODUCT PORTFOLIO 179
16.6.3 RECENT DEVELOPMENT 179
16.7 BRAIN CONTROL CO. LTD 180
16.7.1 COMPANY SNAPSHOT 180
16.7.2 PRODUCT PORTFOLIO 180
16.7.3 RECENT DEVELOPMENTS 180
16.8 CIRTEC 181
16.8.1 COMPANY SNAPSHOT 181
16.8.2 PRODUCT PORTFOLIO 181
16.8.3 RECENT DEVELOPMENTS 181
16.9 MICROTRANSPONDER INC. 182
16.9.1 COMPANY SNAPSHOT 182
16.9.2 PRODUCT PORTFOLIO 182
16.9.3 RECENT DEVELOPMENT 182
16.10 PARASYM LTD 183
16.10.1 COMPANY SNAPSHOT 183
16.10.2 PRODUCT PORTFOLIO 183
16.10.3 RECENT DEVELOPMENT 183
16.11 RESHAPE LIFESCIENCES INC. (2021) 184
16.11.1 COMPANY SNAPSHOT 184
16.11.2 REVENUE ANALYSIS 184
16.11.3 PRODUCT PORTFOLIO 185
16.11.4 RECENT DEVELOPMENT 185
16.12 SOTERIX MEDICAL INC. 186
16.12.1 COMPANY SNAPSHOT 186
16.12.2 PRODUCT PORTFOLIO 186
16.12.3 RECENT DEVELOPMENTS 186
17 QUESTIONNAIRE 187
18 RELATED REPORTS 190
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
